Description
Powerful MAB-CHMINACA | Synthetic Cannabinoid Profile & CB1 Activity
It is a synthetic cannabinoid belonging to the indazole-based cannabinoid class. It is structurally related to AB-FUBINACA and AB-CHMINACA and has been investigated for its interaction with cannabinoid receptors, particularly the CB1 receptor.
Structurally, MAB-CHMINACA shares similarities with AB-CHMINACA, including a cyclohexyl group, while differing in the substitution of its isobutyl moiety with a tert-butyl group. These structural differences are important when distinguishing MAB-CHMINACA from related synthetic cannabinoids during analytical and forensic examination.
It has been reported as a high-affinity ligand for the CB1 receptor. Available data describe it as a potent CB1 receptor agonist, with a reported binding affinity in the sub-nanomolar range. These receptor interactions make the compound relevant to investigations involving synthetic cannabinoid pharmacology and analytical identification.
MAB-CHMINACA has primarily been characterized in scientific and forensic contexts. Its structural relationship to other synthetic cannabinoids makes it relevant to analytical chemistry, toxicology, and forensic investigations where accurate identification of cannabinoid-related compounds is required.
The pharmacological and toxicological characteristics of synthetic cannabinoids can vary substantially between individual compounds, even when their molecular structures are closely related. Consequently, information about related substances should not automatically be applied to it.
Because of its potent receptor activity and limited information concerning its effects and long-term toxicity, MAB-CHMINACA should be handled and analyzed using appropriate laboratory procedures. The compound is intended for applicable analytical, forensic, and scientific purposes rather than general consumer use.
